Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
OMS Energy Technologies Inc. Expands Sustainable Wellhead Refurbishment Program
-
INVESTIGATION NOTICE: Girard Sharp Law Firm Encourages Former Mr. Cooper Group Inc. (NASDAQ: COOP) Investors Who Received Rocket Companies, Inc. (NYSE: RKT) Shares in Connection with Rocket’s Acqui
-
Everything Blockchain (OTC: EBZT) CEO Backs Company with Proposed $300K Personal Credit Line; Major Shareholder Cancels 3.5M Shares to Strengthen Value
-
RadNet to Host Investor Day on November 11, 2025
-
MBOLD Launches ‘Protein Catalyst’ to Drive Animal & Plant Protein Innovation in Rapidly Growing Global Protein Industry
-
Credit Unions to Ottawa: Modernize Financial Rules to Strengthen Competition and Expand Consumer Choice
-
Form 8.5 (EPT/RI) - Greencore Group Plc
-
First Mold to Integrate AI Agents in CNC Machining Management
-
High Tide Resources Provides Update on the Labrador West Iron Ore Project
-
BlackRock® Canada Announces October Cash Distributions for the iShares® ETFs
-
iQIYI to Report Third Quarter 2025 Financial Results on November 18, 2025
-
Mowi’s acquisition of Nova Sea approved
-
Fortescue Announces Early Tender Results of Cash Tender Offers for Certain of Its Debt Securities
-
Same Day Loan Guaranteed Approval: RadCred Offers Urgent Loans for Bad Credit Guaranteed Approval with Instant Matching
-
VEON’s Beeline Kazakhstan to Acquire Online Classifieds Business OLX Kazakhstan
-
InterDigital renews license agreement with Sharp and signs new IoT license
-
VEON’s Beeline Kazakhstan to Acquire Online Classifieds Business OLX Kazakhstan
-
The 67th (Autumn 2025) Pharmaceutical Machinery Exposition Concludes Successfully
-
PrestoDoctor Expands Into Michigan Ahead of New Cannabis Tax Changes
-
RESULT OF RIKSBANK CERTIFICATE SALE
-
Dimensional Fund Advisors Ltd. : Form 8.3 - SPIRE HEALTHCARE GROUP PLC - Ordinary Shares
-
Form 8.5 (EPT/RI)-Dowlais Group plc
-
Dimensional Fund Advisors Ltd. : Form 8.3 - GREENCORE GROUP PLC - Ordinary Shares
-
Form 8.5 (EPT/RI)- NCC Group plc
-
Dimensional Fund Advisors Ltd. : Form 8.3 - DALATA HOTEL GROUP PLC - Ordinary Shares
-
Form 8.5 (EPT/RI)-Treatt plc
-
Form 8.5 (EPT/RI)-PRS Reit PLC
-
Innovation·Defining the Future: JETOUR JMA Global Media Alliance Tech Tour Kicks Off
-
selectION Demonstrates Safety and Disease-Modifying Mechanism of Action of its Investigational Drug, si-544, in Phase 1b Proof-of-Concept Trial in Psoriasis, a T Cell-Mediated Autoimmune Disease
-
selectION Demonstrates Safety and Disease-Modifying Mechanism of Action of its Investigational Drug, si-544, in Phase 1b Proof-of-Concept Trial in Psoriasis, a T Cell-Mediated Autoimmune Disease
-
CONDITIONS FOR SALE OF RIKSBANK CERTIFICATES
-
CECOCECO Brings First Curved ArtMorph Installation to Workspace Design Show Amsterdam 2025
-
Appian and IFC partner to launch new US$1 billion critical minerals and metals fund for emerging markets
-
Nxera’s Partner Cancer Research UK Presents Data from Successfully Completed Phase 1 Clinical Trial of Cancer Immunotherapy Drug HTL0039732 at ESMO
-
Acies Bio doubling biomanufacturing capacity with the construction of 30 m³ bioreactor
-
SiriusPoint Announces Will Nihan as IMG CEO
-
Consensus estimates ahead of Q3 2025
-
Siili Solutions Plc Financial calendar and annual general meeting 2026
-
Municipality Finance issues SEK 1.5 billion tap under its MTN programme
-
St. Mary Capital Begins Formal IPO Preparations Ahead of Anticipated 2026 Listing
-
MEXC Launches SOL Launchpad: New Users Can Subscribe at 50% Off to Share 465 SOL
-
Step Pharma to spotlight work in CTPS2-null solid tumours at 2025 EORTC-NCI-AACR International Conference on Molecular Targets and Cancer Therapeutics
-
Cabka delivers stable Q3 performance in challenging markets and reaffirms focus on profitable growth
-
Siili Solutions Plc, Business review, 1 January–30 September 2025 (unaudited)
-
Eleva advances CPV-104 into Phase 1b clinical testing in patients with C3G, following the successful completion of single ascending dose evaluation in healthy volunteers
-
Equinor ASA: Share buy-back – third tranche for 2025
-
NBPE - Transaction in Own Shares
-
SpringWorks Therapeutics Announces Publication of Long-Term Efficacy and Safety Data from the Phase 3 DeFi Trial of OGSIVEO® (nirogacestat) in Adults with Desmoid Tumors in the Journal of Clinical On
-
Notice to holders of Icelandic Depository Receipts Simplification and streamlining of Amaroq’s securities under a single ISIN
-
PIVOT-PO Phase 3 Data Show Tebipenem HBr’s Potential as the First Oral Carbapenem Antibiotic for Patients with Complicated Urinary Tract Infections (cUTIs)
